BioHarvest Sciences Inc. Common Stock
NASDAQ:BHSTAgricultural Inputs
+$0.08 today
- Market cap
- $50.25M
- Beta
- 1.33
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$0.50
Volume 0.01M
Average 0.03M
BHST Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
BioHarvest Sciences Inc. Common StockNASDAQ: BHST
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue grows, but more slowly than its trailing trend
Q1 FY2026 cost of revenue of $3.47M rose 6.3% year over year, behind the +17.0% change in trailing-twelve-month cost of revenue. Sequentially, it fell 9.7% from the prior quarter. Over 3 fiscal years it compounded at +48.6% a year.
Context
- Cost of revenue amounted to 40.7% of revenue in FY2025, down 4.0 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +6.3% toward the trailing-twelve-month pace of +17.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 14.03M USD
- Year-over-year change
- +24.8%
- 4-year CAGR
- +76.9%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 14.03M | +24.8% |
| FY2024 | 2024-12-31 | 11.25M | +59.8% |
| FY2023 | 2023-12-31 | 7.04M | +64.5% |
| FY2022 | 2022-12-31 | 4.28M | +198.8% |
| FY2021 | 2021-12-31 | 1.43M | — |
Cost of Revenue vs competitors
How BHST compares with its peers on the latest reported figures
- BHST's LTM Mar 2026 cost of revenue of $14.24M is the 8th highest of the 9 companies compared; the peer median is $181.51M.
- Its year-over-year change of +17.0% is the 2nd highest of 8, against a peer median of -4.6%.
- Cost of revenue amounts to 40.5% of revenue for BHST, versus a peer median of 82.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $1.92B | +5.1% | +2.8% | 103.7% | |
| LTM Mar 2026 | $592.64M | +48.5% | +7.5% | 91.6% | |
| LTM Mar 2026 | $367.1M | -12.6% | -0.1% | 70.2% | |
| LTM Mar 2026 | $223.25M | -4.6% | -11.4% | 82.4% | |
| LTM Mar 2026 | $139.77M | -31.1% | -28.1% | 126.9% | |
| LTM Mar 2026 | $59.84M | -42.1% | -35.8% | 78.2% | |
| LTM May 2025 | $32.44M | +11.1% | +83.6% | 61.5% | |
| LTM Mar 2026 | $14.24M | +17.0% | +48.6% | 40.5% | |
USGOU.S. GoldMining Inc. | LTM Feb 2026 | $109.69K | — | — | — |
| Peer median (excluding BHST) | $181.51M | -4.6% | -0.1% | 82.4% | |
Competitors are the stored peer set for BHST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.1M | 5.5M | 12.67M | 25.19M | 34.51M |
| Cost of Revenue | 1.43M | 4.28M | 7.04M | 11.25M | 14.03M |
| Gross Profit | 670K | 1.22M | 5.63M | 13.94M | 20.48M |
| Gross Margin | 31.9% | 22.2% | 44.5% | 55.4% | 59.3% |
| Research & Development | 4.13M | 2.31M | 3.37M | 4.8M | 5.31M |
| Selling, General & Admin | 4.76M | 9.35M | 12.08M | 14.67M | 19.14M |
| Operating Expenses | 9.16M | 11.83M | 15.6M | 20.93M | 26.05M |
| Depreciation & Amortization | 385.58K | 712K | 840K | 1.25M | 1.62M |
| EBITDA | (8.64M) | (9.13M) | (9.76M) | (9.72M) | (6.71M) |
| EBITDA Margin | -410.9% | -166.0% | -77.0% | -38.6% | -19.5% |
| Operating Income | (8.49M) | (10.61M) | (9.97M) | (6.99M) | (5.58M) |
| Operating Margin | -403.9% | -193.0% | -78.6% | -27.7% | -16.2% |
| Interest Income | 0 | 0 | 0 | 0 | 54K |
| Interest Expense | 805K | 1.4M | 1.96M | 1.93M | 2.72M |
| Other Income / Expenses | (1.34M) | (624K) | (2.6M) | (5.92M) | (5.48M) |
| Income Before Tax | (9.83M) | (11.24M) | (12.56M) | (12.91M) | (11.06M) |
| Pre-Tax Margin | -467.5% | -204.4% | -99.1% | -51.2% | -32.0% |
| Income Tax Expense | 0 | 0 | 0 | 8K | 76K |
| Net Income | (9.83M) | (11.24M) | (12.56M) | (12.91M) | (11.14M) |
| Net Margin | -467.5% | -204.4% | -99.1% | -51.3% | -32.3% |
| EPS (Basic) | (0.70) | (0.70) | (0.93) | (0.80) | (0.60) |
| EPS (Diluted) | (0.70) | (0.70) | (0.93) | (0.80) | (0.60) |
| Weighted Avg Shares | 12.45M | 13.05M | 13.53M | 16.19M | 18.41M |
| Weighted Avg Shares (Diluted) | 12.45M | 13.05M | 13.53M | 16.19M | 18.41M |
BioHarvest Sciences Inc. Common Stock
NASDAQ:BHST
Intrinsic Alpha fair value
Locked
Current Price
$2.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.